Final analysis of Australasian Leukaemia & Lymphoma Group NHL29: A phase II study of ibrutinib, rituximab and mini-CHOP in very elderly patients with newly diagnosed DLBCL

E. Verner; A. Johnston; N. Pati; E. Hawkes; H. P. Lee; T. Cochrane; C. Y. Cheah; R. Filshie; D. Purtill; H. Sia; A. K. Enjeti; C. Brown; N. Murphy; J. Curnow; K. Lee; M. K. Gandhi; B. E. Butcher; J. Trotman

doi:10.1002/hon.3164_313

Final analysis of Australasian Leukaemia & Lymphoma Group NHL29: A phase II study of ibrutinib, rituximab and mini-CHOP in very elderly patients with newly diagnosed DLBCL

E. Verner, A. Johnston, N. Pati, E. Hawkes, H. P. Lee, T. Cochrane, C. Y. Cheah, R. Filshie, D. Purtill, H. Sia, A. K. Enjeti, C. Brown, N. Murphy, J. Curnow, K. Lee, M. K. Gandhi, B. E. Butcher, J. Trotman

Research output: Contribution to journal › Meeting Abstract › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	426-427
Number of pages	2
Journal	Hematological Oncology
Volume	41
Issue number	S2
DOIs	https://doi.org/10.1002/hon.3164_313
Publication status	Published - Jun 2023
Externally published	Yes
Event	International Conference on Malignant Lymphoma 2023 - Palazzo dei Congressi, Lugano, Switzerland Duration: 13 Jun 2023 → 17 Jun 2023 Conference number: 17th https://onlinelibrary.wiley.com/toc/10991069/2023/41/S2

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1002/hon.3164_313

Cite this

Verner, E., Johnston, A., Pati, N., Hawkes, E., Lee, H. P., Cochrane, T., Cheah, C. Y., Filshie, R., Purtill, D., Sia, H., Enjeti, A. K., Brown, C., Murphy, N., Curnow, J., Lee, K., Gandhi, M. K., Butcher, B. E., & Trotman, J. (2023). Final analysis of Australasian Leukaemia & Lymphoma Group NHL29: A phase II study of ibrutinib, rituximab and mini-CHOP in very elderly patients with newly diagnosed DLBCL. Hematological Oncology, 41(S2), 426-427. https://doi.org/10.1002/hon.3164_313

@article{8673cadddac444f8b364e79755c1502a,

title = "Final analysis of Australasian Leukaemia \& Lymphoma Group NHL29: A phase II study of ibrutinib, rituximab and mini-CHOP in very elderly patients with newly diagnosed DLBCL",

author = "E. Verner and A. Johnston and N. Pati and E. Hawkes and Lee, \{H. P.\} and T. Cochrane and Cheah, \{C. Y.\} and R. Filshie and D. Purtill and H. Sia and Enjeti, \{A. K.\} and C. Brown and N. Murphy and J. Curnow and K. Lee and Gandhi, \{M. K.\} and Butcher, \{B. E.\} and J. Trotman",

year = "2023",

month = jun,

doi = "10.1002/hon.3164\_313",

language = "English",

volume = "41",

pages = "426--427",

journal = "Hematological Oncology",

issn = "1099-1069",

publisher = "Wiley-Blackwell",

number = "S2",

note = "International Conference on Malignant Lymphoma 2023 , 17-ICML ; Conference date: 13-06-2023 Through 17-06-2023",

url = "https://onlinelibrary.wiley.com/toc/10991069/2023/41/S2",

}

Verner, E, Johnston, A, Pati, N, Hawkes, E, Lee, HP, Cochrane, T, Cheah, CY, Filshie, R, Purtill, D, Sia, H, Enjeti, AK, Brown, C, Murphy, N, Curnow, J, Lee, K, Gandhi, MK, Butcher, BE & Trotman, J 2023, 'Final analysis of Australasian Leukaemia & Lymphoma Group NHL29: A phase II study of ibrutinib, rituximab and mini-CHOP in very elderly patients with newly diagnosed DLBCL', Hematological Oncology, vol. 41, no. S2, pp. 426-427. https://doi.org/10.1002/hon.3164_313

TY - JOUR

T1 - Final analysis of Australasian Leukaemia & Lymphoma Group NHL29

T2 - International Conference on Malignant Lymphoma 2023

AU - Verner, E.

AU - Johnston, A.

AU - Pati, N.

AU - Hawkes, E.

AU - Lee, H. P.

AU - Cochrane, T.

AU - Cheah, C. Y.

AU - Filshie, R.

AU - Purtill, D.

AU - Sia, H.

AU - Enjeti, A. K.

AU - Brown, C.

AU - Murphy, N.

AU - Curnow, J.

AU - Lee, K.

AU - Gandhi, M. K.

AU - Butcher, B. E.

AU - Trotman, J.

N1 - Conference code: 17th

PY - 2023/6

Y1 - 2023/6

UR - https://www.scopus.com/pages/publications/85194996284

U2 - 10.1002/hon.3164_313

DO - 10.1002/hon.3164_313

M3 - Meeting Abstract

C2 - 39112176

AN - SCOPUS:85194996284

SN - 1099-1069

VL - 41

SP - 426

EP - 427

JO - Hematological Oncology

JF - Hematological Oncology

IS - S2

Y2 - 13 June 2023 through 17 June 2023

ER -

Final analysis of Australasian Leukaemia & Lymphoma Group NHL29: A phase II study of ibrutinib, rituximab and mini-CHOP in very elderly patients with newly diagnosed DLBCL

UN SDGs

Access to Document

Other files and links

Cite this